139 related articles for article (PubMed ID: 19609944)
1. Tissue inhibitor of metalloproteinase-1 protects MCF-7 breast cancer cells from paclitaxel-induced apoptosis by decreasing the stability of cyclin B1.
Wang T; Lv JH; Zhang XF; Li CJ; Han X; Sun YJ
Int J Cancer; 2010 Jan; 126(2):362-70. PubMed ID: 19609944
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1.
Dong XL; Xu PF; Miao C; Fu ZY; Li QP; Tang PY; Wang T
Biomed Pharmacother; 2012 Feb; 66(1):70-5. PubMed ID: 22264882
[TBL] [Abstract][Full Text] [Related]
3. The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel.
Sakashita F; Osada S; Takemura M; Imai H; Tomita H; Nonaka K; Takahashi T; Seishima M
Cancer Chemother Pharmacol; 2008 Aug; 62(3):379-85. PubMed ID: 17960385
[TBL] [Abstract][Full Text] [Related]
4. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
Choi YH; Yoo YH
Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
[TBL] [Abstract][Full Text] [Related]
5. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells.
Pratt MA; Niu MY; Renart LI
Apoptosis; 2006 Apr; 11(4):589-605. PubMed ID: 16528475
[TBL] [Abstract][Full Text] [Related]
6. Tissue inhibitor of metalloproteinase-1 decreased chemosensitivity of MDA-435 breast cancer cells to chemotherapeutic drugs through the PI3K/AKT/NF-кB pathway.
Fu ZY; Lv JH; Ma CY; Yang DP; Wang T
Biomed Pharmacother; 2011 Jun; 65(3):163-7. PubMed ID: 21684102
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity.
Henley D; Isbill M; Fernando R; Foster JS; Wimalasena J
Cancer Chemother Pharmacol; 2007 Feb; 59(2):235-49. PubMed ID: 16972069
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y
Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096
[TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent kinase 1 inhibitor RO3306 promotes mitotic slippage in paclitaxel-treated HepG2 cells.
Xiao J; Qiu P; Lai X; He P; Wu Y; Du B; Tan Y
Neoplasma; 2014; 61(1):41-7. PubMed ID: 24195507
[TBL] [Abstract][Full Text] [Related]
10. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
Giannakakou P; Robey R; Fojo T; Blagosklonny MV
Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
[TBL] [Abstract][Full Text] [Related]
11. Physalis angulata induced G2/M phase arrest in human breast cancer cells.
Hsieh WT; Huang KY; Lin HY; Chung JG
Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death.
Sui M; Huang Y; Park BH; Davidson NE; Fan W
Cancer Res; 2007 Jun; 67(11):5337-44. PubMed ID: 17545614
[TBL] [Abstract][Full Text] [Related]
13. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells.
Motwani M; Delohery TM; Schwartz GK
Clin Cancer Res; 1999 Jul; 5(7):1876-83. PubMed ID: 10430095
[TBL] [Abstract][Full Text] [Related]
14. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
Ho TF; Peng YT; Chuang SM; Lin SC; Feng BL; Lu CH; Yu WJ; Chang JS; Chang CC
Toxicol Appl Pharmacol; 2009 Mar; 235(2):253-60. PubMed ID: 19133282
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone.
Sugimura M; Sagae S; Ishioka S; Nishioka Y; Tsukada K; Kudo R
Oncology; 2004; 66(1):53-61. PubMed ID: 15031599
[TBL] [Abstract][Full Text] [Related]
16. Role of cyclin B1/Cdc2 up-regulation in the development of mitotic prometaphase arrest in human breast cancer cells treated with nocodazole.
Choi HJ; Fukui M; Zhu BT
PLoS One; 2011; 6(8):e24312. PubMed ID: 21918689
[TBL] [Abstract][Full Text] [Related]
17. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123
[TBL] [Abstract][Full Text] [Related]
18. RAD6 inhibition enhances paclitaxel sensitivity of triple negative breast cancer cells by aggravating mitotic spindle damage.
Haynes BM; Cunningham K; Shekhar MPV
BMC Cancer; 2022 Oct; 22(1):1073. PubMed ID: 36258187
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-induced apoptosis is blocked by camptothecin in human breast and pancreatic cancer cells.
Jeansonne DP; Koh GY; Zhang F; Kirk-Ballard H; Wolff L; Liu D; Eilertsen K; Liu Z
Oncol Rep; 2011 May; 25(5):1473-80. PubMed ID: 21331447
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol interference with the cell cycle protects human neuroblastoma SH-SY5Y cell from paclitaxel-induced apoptosis.
Rigolio R; Miloso M; Nicolini G; Villa D; Scuteri A; Simone M; Tredici G
Neurochem Int; 2005 Feb; 46(3):205-11. PubMed ID: 15670636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
